No Detail Found!

Regional neurochemical profile following co-administration of apomorphine and buspirone in an animal model of addiction

Author(s)
Huma Ikram Neurochemistry and Biochemical Neuropharmacology Research Unit, Department of Biochemistry, University of Karachi,Karachi-,Pakistan
Darakhshan Jabeen Haleem Neuroscience Research Laboratory, Dr. Panjwani Center for Molecular Medicine and Drug Research, University of Karachi,Karachi,Pakistan
Abstract
Although dopamine is the primary neurotransmitter mediating the reinforcing outcomes of abused drugs, serotonin (5-hydroxytryptamine; 5HT) also performs an important function in addiction pathophysiology. Increased dopamine levels in the nucleus accumbens mediate the final effects of various drugs of abuse, regardless of their exceptional preliminary binding sites. Repeated administration of apomorphine has been reported to supersensitize 5HT1A receptors, and buspirone could attenuate these effects. The present study applied the conditioned place preference (CPP) test to screen apomorphine's reinforcing outcomes and their attenuation by means of co-administration of buspirone. Associated adjustments in 5-HT and dopamine metabolism in various brain regions were monitored using HPLC-EC. Withdrawal from apomorphine administration (1.0 mg/kg on 12 alternate days) brought about reinforcement as observed in the CPP paradigm. Serotonin and dopamine metabolism, mainly in the ventral and dorsal striatum, became additionally altered. The effects propose that desensitization of presynaptic dopamine receptors is concerned in apomorphine-induced reinforcement. Desensitization of somatodendritic 5HT-1A receptors, ensuing in expanded availability of 5HT at 5HT-2C receptors, could attenuate apomorphine-brought about reinforcement. These findings may additionally potentiate the therapeutic applicability of apomorphine.
Publication Details
Page(s) 2168-2175
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 6, Year: 2025

Request the full text from PASTIC

Keywords
buspirone, Hippocampus, Prefrontal Cortex, Apomorphine, Ventral striatum, Hypothalamus and prefrontal cortex, Mid brain, Dorsal striatum
References
Avramescu RG,Hernandez G,Flores C .2024 .Rewiring the future: Drugs abused in adolescence may predispose to mental illness in adult life by altering dopamine axon growth. J. Neural. Transm., 131 : 461-467.
Kieffer Darcq E,BL Darcq E .2024 .Neuroscience and addiction research: Current advances and perspectives. J. Neural. Transm., 131(5) : 405-408.
Diepenbroek C,Rijnsburger M,van Irsen AAS,Eggels L,Kisner A,Foppen E,Unmehopa UA,Berland C,Dolleman S,Hardonk M,Cruciani-Guglielmacci C,Faust RP,Wenning R,Maya-Monteiro CM,Kalsbeek A,Aponte Y,Luquet S,Serlie MJM .2024 .Dopamine in the nucleus accumbens shell controls systemic glucose metabolism via the lateral hypothalamus and hepatic vagal innervation in rodents. Metabolism, 150 : 155696.
Duval F .2023 .Systematic review of the apomorphine challenge test in the assessment of dopaminergic activity in schizophrenia. Healthcare (Basel), 11(10) : 1487.
Estav PM,Albertson SE,Karkhanis AN,Jones SR .2024 .Co-targeting the kappa opioid receptor and dopamine transporter reduces motivation to selfadminister cocaine and partially reverses dopamine system dysregulation. Sci. Rep, 14 : 6509.
Ferron JC,Brunette MF,Aschbrenner KA,ElSayed MW,Pratt SI .2024 .Tobacco, alcohol, and drug use among young adults with serious mental illness. Community, 60(5) : 945-954.
Haleem DJ,Ikram H,Haleem MA H .2014 .Inhibition of apomorphine-induced conditioned place preference in rats co-injected with buspirone: Relationship with serotonin and dopamine in the striatum. Brain Res., 1586 : 73-82.
Hur KH,Lee Y,Donio AL,Kim SK,Lee BR,Seo JY,Kundu D,Kim KM,Kohut SJ,Lee SY,Jang CG .2024 .Transient receptor potential ankyrin 1 channel modulates the abuse-related mechanisms of methamphetamine through interaction with dopamine transporter. Br. J. Pharmacol., 181(16) : 2794-2809.
Ikram H,Masood R,Syed S,Haleem DJ S .2023 .Neuropharmacological studies on repurposed utilization of pioglitazone in learning and memory: A dose related study. Pak. J. Pharm. Sci., 36(4) : 1159-1167.
Ikram H,Tasneem S,Perveen S,Zakir R,Haleem DJ R .2021 .Neurochemical and behavioral effects of fluoxetine on midazolam induce dependence in an animal model of addiction. Pak. J. Pharm. Sci., 34(5) : 1749-1757.
Ikram H,Zakir R,Haleem DJ R,Jami ES,Hammerschlag AR,Sallis HM,Qiao Z,Andreassen OA,Magnus PM,Njølstad PR,Havdahl A,Pingault JB,Evans DM,Munafò MR,Ystrom E,Bartels M,Middeldorp C M .2023 .Do environmental effects indexed by parental genetic variation influence common psychiatric symptoms in childhood? Transl. Metab. Brain Dis, 13(1) : 94.
Jastrzębska J,Frankowska M,Smaga I,HubalewskaMazgaj M,Suder A,Pieniążek R,Filip M .2023 .Evaluation of the 5-HT2C receptor drugs RO 60-0175, WAY 161503 and mirtazepine in a preclinical model of comorbidity of depression and cocaine addiction. Pharmacol. Rep, 75 : 99-118.
Jastrzębska J,Frankowska M,Smaga I,HubalewskaMazgaj M,Suder A,Pieniążek R,Przegaliński E,Filip M .2023 .Evaluation of the 5-HT2C receptor drugs RO 60-0175, WAY 161503 and mirtazepine in a preclinical model of comorbidity of depression and cocaine addiction. Pharmacol. Rep, 75(1) : 99-118.
Jones BLH,Geier M,Neuhaus J,Coffin PO,Snyder HR,Soran CS,Knight KR,Suen LW .2024 .Withdrawal during outpatient low dose buprenorphine initiation in people who use fentanyl: A retrospective cohort study. Harm, 21(1) : 80.
Kassubek J,Factor SA,Balaguer E,Schwarz J,Chaudhuri RK,Isaacson SH,Wu S,Muhr CD,Kulisevsky T .2024 .Long-term safety, tolerability and efficacy of apomorphine sublingual film in patients with Parkinson's disease complicated by OFF episodes: a phase 3, open-label study. J. Neurol., 271 : 3554-3570.
Kassubek J,Jost WH,Schwarz J .2024 .Sublingual apomorphine in the treatment of Parkinson's disease. J. Neural. Transm., (Vienna), 131(10) : 1209-1216.
Kohtz AS,Zhao J,Aston-Jones G .2024 .Serotonin signaling in hippocampus during initial cocaine abstinence drives persistent drug seeking. J. Neurosci., 44(17) : e1505212024.
Koijam AS,Singh KD,Nameirakpam BS,Haobam R,Rajashekar Y .2024 .Drug addiction and treatment: An epigenetic perspective. , 170 : 115951.
Lauretani F,Giallauria F,Testa C,Zinni C,Lorenzi B,Zucchini I,Salvi M,Napoli R,Maggio MG .2024 .Dopamine pharmacodynamics: New insights. Int. J. Mol. Sci, 25(10) : 5293.
Monari PK,Hammond ER,Zhao X,Maksimoski AN,Petric R,Malone CL,Riters LV,Marler CA .2024 .Conditioned preferences: Gated by experience, context, and endocrine systems. Horm. Behav, 161 : 105529.
Negus SS .2024 .An economon model of drug addiction. Psychopharmacology (Berl), 241(3) : 417-425.
Porrino LJ,Smith HR,Beveridge TJR,Miller MD,Nader SH,Nader MA .2023 .Prolonged exposure to cocaine self-administration results in a continued progression of alterations in functional activity in a nonhuman primate model. Drug Alcohol Depend. Rep, 7(1) : 100148.
Tromp DPM,Fox AS,Riedel MK,Oler JA,Zhou X,Roseboom PH,Alexander AL,Kalin NH .2024 .Early life adversity in primates: Behavioral, endocrine, and neural effects. , 162 : 106953.
Wang X,Chen Y,Dong J,Ge J,Liu X,Liu J .2024 .Neurobiology of stress-induced nicotine relapse. Int. J. Mol. Sci, 25(3) : 1482.
Yuan S,Jiang SC,Zhang ZW,Li ZL,Hu J .2024 .Substance addiction rehabilitation drugs. Pharmaceuticals, 17(5) : 615.
0

Citations

0

Downloads

73

Views